DK1789395T3 - Fremgangsmåde til chiral inversion af (S)-(+)- og (R)-(-)-10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepin-5-carboxamid og optisk berigede blandinger deraf - Google Patents

Fremgangsmåde til chiral inversion af (S)-(+)- og (R)-(-)-10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepin-5-carboxamid og optisk berigede blandinger deraf

Info

Publication number
DK1789395T3
DK1789395T3 DK05759707T DK05759707T DK1789395T3 DK 1789395 T3 DK1789395 T3 DK 1789395T3 DK 05759707 T DK05759707 T DK 05759707T DK 05759707 T DK05759707 T DK 05759707T DK 1789395 T3 DK1789395 T3 DK 1789395T3
Authority
DK
Denmark
Prior art keywords
dibenz
azepine
carboxamide
dihydro
hydroxy
Prior art date
Application number
DK05759707T
Other languages
Danish (da)
English (en)
Inventor
David Alexander Learmonth
Guenter Weingaertner
Matthias Kraemer
Original Assignee
Bial Portela & Ca Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bial Portela & Ca Sa filed Critical Bial Portela & Ca Sa
Application granted granted Critical
Publication of DK1789395T3 publication Critical patent/DK1789395T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK05759707T 2004-07-13 2005-07-13 Fremgangsmåde til chiral inversion af (S)-(+)- og (R)-(-)-10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepin-5-carboxamid og optisk berigede blandinger deraf DK1789395T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0415664A GB2416167A (en) 2004-07-13 2004-07-13 Chiral inversion and esterification of (S)- and (R)-10-hydroxy-dibenzazepine carboxamides
PCT/GB2005/002744 WO2006005951A1 (en) 2004-07-13 2005-07-13 Method for chiral inversion of (s)-(+)- and (r)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and optically enriched mixtures thereof

Publications (1)

Publication Number Publication Date
DK1789395T3 true DK1789395T3 (da) 2009-04-20

Family

ID=32893499

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05759707T DK1789395T3 (da) 2004-07-13 2005-07-13 Fremgangsmåde til chiral inversion af (S)-(+)- og (R)-(-)-10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepin-5-carboxamid og optisk berigede blandinger deraf

Country Status (20)

Country Link
US (1) US7999100B2 (pt)
EP (1) EP1789395B8 (pt)
JP (1) JP2008506676A (pt)
CN (1) CN100582095C (pt)
AR (1) AR050170A1 (pt)
AT (1) ATE420864T1 (pt)
AU (1) AU2005261497A1 (pt)
BR (1) BRPI0513383A (pt)
CA (1) CA2574002C (pt)
DE (1) DE602005012405D1 (pt)
DK (1) DK1789395T3 (pt)
ES (1) ES2320155T3 (pt)
GB (1) GB2416167A (pt)
HR (1) HRP20090212T1 (pt)
MX (1) MX2007000575A (pt)
PL (1) PL1789395T3 (pt)
PT (1) PT103308B (pt)
RU (1) RU2382772C2 (pt)
SI (1) SI1789395T1 (pt)
WO (1) WO2006005951A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0515690D0 (en) 2005-07-29 2005-09-07 Portela & Ca Sa Asymmetric catalytic reduction
GB2437078A (en) * 2006-04-11 2007-10-17 Portela & Ca Sa 10-Acyloxy-5H-dibenzo[b,f]azepine-5-carboxamides & their asymmetric hydrogenation to the chiral 10,11-dihydro derivatives
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
US8372431B2 (en) 2007-10-26 2013-02-12 Bial-Portela & C.A., S.A. Pharmaceutical composition comprising licarbazepine acetate
WO2010113179A2 (en) * 2009-04-02 2010-10-07 Glenmark Generics Limited A process for the purification of eslicarbazepine acetate
RU2012106827A (ru) 2009-07-27 2013-09-10 БИАЛ-ПОРТЕЛА энд КА., С.А. Применение производных 5н-дибенз/в, f/азепин-5-карбоксамида для лечения фибромиалгии
WO2011045648A2 (en) * 2009-10-12 2011-04-21 Matrix Laboratories Limited Process for preparing (s)-(-)-10-acetoxy-10,11-dihydro-5h-dibenz[b,f]azepine-5-carboxamide and its esters thereof
WO2011091131A2 (en) * 2010-01-23 2011-07-28 Dr. Reddy's Laboratories Ltd. Eslicarbazepine acetate and its polymorphs
WO2011117885A1 (en) * 2010-03-23 2011-09-29 Intas Pharmaceuticals Limited Process for preparation of enantiomers of licarbazepine
WO2012120356A2 (en) 2011-03-08 2012-09-13 Jubilant Life Sciences Limited Process for the preparation of (s)-(+)-or (r)-(-)-10 hydroxy dihydrodibenz[b,f]azepines by enantioselective reduction of 10, 11-dihydro-10-oxo-5h-dibenz[b,f]azepines and polymorphs thereof
WO2012156987A2 (en) * 2011-05-19 2012-11-22 Glenmark Generics Limited A novel process for the preparation of eslicarbazepine
US20150065704A1 (en) 2011-07-13 2015-03-05 Ketan Hirpara Process for the preparation and purification of eslicarbazepine acetate and intermediates thereof
WO2014049550A1 (en) 2012-09-26 2014-04-03 Ranbaxy Laboratories Limited Process for the preparation of oxcarbazepine and its use as intermediate in the preparation of eslicarbazepine acetate
EP3064490A1 (en) 2015-03-06 2016-09-07 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Improved process for the preparation of eslicarbazepine and eslicarbazepine acetate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT101732B (pt) * 1995-06-30 1997-12-31 Portela & Ca Sa Novas di-hidrodibenzo<b,f>azepinas substituidas processo para a sua preparacao composicoes farmaceuticas que as contem e utilizacao dos novos compostos na preparacao de composicoes farmaceuticas empregues em doencas do sistema nervoso
GB0111566D0 (en) * 2001-05-11 2001-07-04 Portela & Ca Sa Method for preparation of (s)-(+)-and (r)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azephine-5-carboxamide

Also Published As

Publication number Publication date
DE602005012405D1 (de) 2009-03-05
GB2416167A (en) 2006-01-18
CA2574002C (en) 2014-02-04
GB0415664D0 (en) 2004-08-18
PT103308B (pt) 2008-06-11
RU2007105228A (ru) 2008-08-20
EP1789395B8 (en) 2009-08-12
SI1789395T1 (sl) 2009-06-30
EP1789395A1 (en) 2007-05-30
CN101023061A (zh) 2007-08-22
HRP20090212T1 (hr) 2009-09-30
WO2006005951A1 (en) 2006-01-19
JP2008506676A (ja) 2008-03-06
AU2005261497A1 (en) 2006-01-19
RU2382772C2 (ru) 2010-02-27
ATE420864T1 (de) 2009-01-15
PL1789395T3 (pl) 2009-06-30
CN100582095C (zh) 2010-01-20
BRPI0513383A (pt) 2008-05-06
AR050170A1 (es) 2006-10-04
US20080293934A1 (en) 2008-11-27
MX2007000575A (es) 2007-03-30
ES2320155T3 (es) 2009-05-19
PT103308A (pt) 2007-01-31
US7999100B2 (en) 2011-08-16
EP1789395B1 (en) 2009-01-14
CA2574002A1 (en) 2006-01-19

Similar Documents

Publication Publication Date Title
DK1789395T3 (da) Fremgangsmåde til chiral inversion af (S)-(+)- og (R)-(-)-10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepin-5-carboxamid og optisk berigede blandinger deraf
DK1824475T3 (da) Fremgangsmåde til oprensning af trans-(-)-delta9-tetrahydrocannabinol og trans-(+)-delta9-tetrahydrocannabinol
DK1667986T3 (da) Acetonesolvat af dimethoxydocetaxel og fremgangsmåde til fremstilling heraf
DE602004012554D1 (de) Optisches verfahren und analysator
DE602004008386D1 (de) System und Methode zur Herstellung von Brillengläsern, Programm und Medium
ATE452883T1 (de) KRISTALLINE FORM VON 1-CHLOR-4-(ß-D-GLUCOPYRANOS- 1-YL)-2-Ä4-((S)-TETRAHYDROFURAN-3-YLOXY)- BENZYLÜBENZOL, VERFAHREN ZU DESSEN HERSTELLUNG UND DESSEN VERWENDUNG ZUR HERSTELLUNG VON MEDIKAMENTEN
DK2308507T3 (da) Fremgangsmåder til behandling af præeklampsi
DE602005015473D1 (de) Verfahren und mittel zur herstellung von hyaluronan
DK1564202T3 (da) Ny fremgangsmåde til fremsitlling af og en ny krystalform af agomelation samt farmaceutiske sammensætninger indeholdende denne
DE502005008601D1 (de) Optisches Bauteil aus Quarzglas, Verfahren zur Herstellung des Bauteils und Verwendung desselben
DK1642897T3 (da) Alfa-krystalform af strontiumranelat, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
DE102004021156A8 (de) Flüssigkristalldisplay und Verfahren zu dessen Herstellung
DK1477480T3 (da) Fremgangsmåde til racemisering af (S)-(+)- og (R)-(-)-10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepin-5-carboxamid og optisk berigede blandinger deraf
IL176216A0 (en) All-optical, 3r regeneration using the sagnac, and mach-zehnder versions of the terahertz optical asymmetric demultiplexer (toad)
DE602005001383D1 (de) Optisches Taktrückgewinnungs-Verfahren und zugehörige Vorrichtung
DE602006018129D1 (de) Codierer, decodierer und verfahren dafür
ATE406372T1 (de) Verfahren zur herstellung von 3-o-geschützten morphinonen und 3-o-geschützten morphinondienolcarboxylaten
DK1745844T3 (da) System og fremgangsmåde til bortskaffelse af urenheder
DK1668125T3 (da) Modificerede enzymer, fremgangsmåde til fremstilling af modificerede enzymer og anvendelser deraf
ATE394369T1 (de) Verfahren zur aufreinigung von mesotrion
FI20030771A (fi) Menetelmä toksisten syanobakteerien määrittämiseksi
DE602004031350D1 (de) Penamkristall und verfahren zu dessen herstellung
DK1575941T3 (da) Fremgangsmåde til fremstilling af (S)-pantoprazol
DK1502590T3 (da) Heterocykliske oximderivater, fremgangsmåde til fremstilling heraf og anvendelse heraf ved behandling af diabetes type II
DK1656365T3 (da) Fremgangsmåde til fremstilling af enantiomerisk rent mirtazapin